Author:
Anderson Shelby,Luffer-Atlas Debra,Pat Knadler Mary
Reference90 articles.
1. US Food and Drug Administration Draft guidance for industry: drug interaction studies- study design, data analysis, and implications for dosing and labeling FDA Rockville, MD 2006
2. Committee for Proprietary Medicinal Products Note for guidance on the investigation of drug interactions 1998
3. Drug metabolites in safety testing;Baillie;Toxicol Appl Pharmacol,2002
4. Seeing through the MIST: abundance versus percentage. Commentary of metabolites in safety testing;Smith;Drug Metab Dispos,2005
5. A regulatory perspective on issues and approaches in characterizing human metabolites;Davis-Bruno;Chem Res Toxicol,2006